Elissa Ball is a former data analysis intern for Spectrum. Prior to coming here, she worked in the Yonkers Public Library and as a tutor for Kaplan Test Prep. She earned a bachelor’s degree in anthropology, with a minor in mechanical engineering, from the University of Pennsylvania, in Philadelphia.
Elissa Ball
From this contributor
Why autism training for police isn’t enough
Inconsistent and underfunded training programs may hurt more than they help, experts say.
Why autism training for police isn’t enough
Autistic and non-autistic youth get different healthcare as they age
Young people with autism receive more mental health services, more consistent primary care and less gynecological or urgent care than their neurotypical peers.
Autistic and non-autistic youth get different healthcare as they age
Almost one-third of autistic children in the United States live in poverty
Children younger than age 5 and Black and Hispanic children on the spectrum experience the most financial hardships.
Almost one-third of autistic children in the United States live in poverty
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.